Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Oct;65(10):4322–4329. doi: 10.1128/iai.65.10.4322-4329.1997

Spiralin, a mycoplasmal membrane lipoprotein, induces T-cell-independent B-cell blastogenesis and secretion of proinflammatory cytokines.

C Brenner 1, H Wróblewski 1, M Le Henaff 1, L Montagnier 1, A Blanchard 1
PMCID: PMC175619  PMID: 9317043

Abstract

Mycoplasmas are bacteria which can cause respiratory, arthritic, and urogenital diseases. During the early phase of infection, mycoplasmas usually induce an inflammatory response and a humoral response preferentially directed against their membrane-bound, surface-exposed lipoproteins. In this report, we describe the effects on immune cells of spiralin, a well-characterized mycoplasmal lipoprotein. Purified spiralin stimulated the in vitro proliferation of human peripheral blood mononuclear cells and murine splenocytes. The stimulation pathway was probably different from that followed by Escherichia coli lipopolysaccharide because the effect of spiralin was not abolished by polymyxin B. Comparison of the effects of whole, native spiralin with those induced by proteinase K-digested spiralin or by the C-terminal half of spiralin (peptide p[13.5]T) revealed that the first half of the protein, which contains the lipoylated N terminus, is responsible for the mitogenic activity. In contrast to whole spiralin, proteinase K-digested spiralin did not trigger murine B-cell differentiation and immunoglobulin G and M secretion. Stimulation of human or murine immune cells led to early secretion of proinflammatory cytokines (human tumor necrosis factor alpha and murine interleukin 1 or 6). Spiralin induced the T-cell-independent blastogenesis of murine B cells but did not stimulate T cells. Altogether, our data demonstrate that spiralin possesses potent immunostimulating activity, similar to that reported for lipoproteins of pathogenic gracilicutes (gram-negative eubacteria; e.g., Borrelia burgdorferi OspA and E. coli Braun lipoprotein), and are consistent with the fact that lipoproteins are major antigens during mycoplasma infections.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berg M., Offermanns S., Seifert R., Schultz G. Synthetic lipopeptide Pam3CysSer(Lys)4 is an effective activator of human platelets. Am J Physiol. 1994 Jun;266(6 Pt 1):C1684–C1691. doi: 10.1152/ajpcell.1994.266.6.C1684. [DOI] [PubMed] [Google Scholar]
  2. Bessler W. G., Jung G. Synthetic lipopeptides as novel adjuvants. Res Immunol. 1992 Jun;143(5):548–580. doi: 10.1016/0923-2494(92)80067-u. [DOI] [PubMed] [Google Scholar]
  3. Brenner C., Duclohier H., Krchnák V., Wróblewski H. Conformation, pore-forming activity, and antigenicity of synthetic peptide analogues of a spiralin putative amphipathic alpha helix. Biochim Biophys Acta. 1995 May 4;1235(2):161–168. doi: 10.1016/0005-2736(95)80001-v. [DOI] [PubMed] [Google Scholar]
  4. Béven L., Le Hénaff M., Fontenelle C., Wróblewski H. Inhibition of spiralin processing by the lipopeptide antibiotic globomycin. Curr Microbiol. 1996 Nov;33(5):317–322. doi: 10.1007/s002849900121. [DOI] [PubMed] [Google Scholar]
  5. Cartner S. C., Simecka J. W., Briles D. E., Cassell G. H., Lindsey J. R. Resistance to mycoplasmal lung disease in mice is a complex genetic trait. Infect Immun. 1996 Dec;64(12):5326–5331. doi: 10.1128/iai.64.12.5326-5331.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chevalier C., Saillard C., Bove J. M. Spiralins of Spiroplasma citri and Spiroplasma melliferum: amino acid sequences and putative organization in the cell membrane. J Bacteriol. 1990 Oct;172(10):6090–6097. doi: 10.1128/jb.172.10.6090-6097.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cole B. C., Atkin C. L. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol Today. 1991 Aug;12(8):271–276. doi: 10.1016/0167-5699(91)90125-D. [DOI] [PubMed] [Google Scholar]
  8. Erdile L. F., Brandt M. A., Warakomski D. J., Westrack G. J., Sadziene A., Barbour A. G., Mays J. P. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect Immun. 1993 Jan;61(1):81–90. doi: 10.1128/iai.61.1.81-90.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Faulkner C. B., Simecka J. W., Davidson M. K., Davis J. K., Schoeb T. R., Lindsey J. R., Everson M. P. Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect Immun. 1995 Oct;63(10):4084–4090. doi: 10.1128/iai.63.10.4084-4090.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Feng S. H., Lo S. C. Induced mouse spleen B-cell proliferation and secretion of immunoglobulin by lipid-associated membrane proteins of Mycoplasma fermentans incognitus and Mycoplasma penetrans. Infect Immun. 1994 Sep;62(9):3916–3921. doi: 10.1128/iai.62.9.3916-3921.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ferris S., Watson H. L., Neyrolles O., Montagnier L., Blanchard A. Characterization of a major Mycoplasma penetrans lipoprotein and of its gene. FEMS Microbiol Lett. 1995 Aug 1;130(2-3):313–319. doi: 10.1111/j.1574-6968.1995.tb07737.x. [DOI] [PubMed] [Google Scholar]
  12. Foissac X., Saillard C., Gandar J., Zreik L., Bové J. M. Spiralin polymorphism in strains of Spiroplasma citri is not due to differences in posttranslational palmitoylation. J Bacteriol. 1996 May;178(10):2934–2940. doi: 10.1128/jb.178.10.2934-2940.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Herbelin A., Ruuth E., Delorme D., Michel-Herbelin C., Praz F. Mycoplasma arginini TUH-14 membrane lipoproteins induce production of interleukin-1, interleukin-6, and tumor necrosis factor alpha by human monocytes. Infect Immun. 1994 Oct;62(10):4690–4694. doi: 10.1128/iai.62.10.4690-4694.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jan G., Fontenelle C., Le Hénaff M., Wróblewski H. Acylation and immunological properties of Mycoplasma gallisepticum membrane proteins. Res Microbiol. 1995 Nov-Dec;146(9):739–750. doi: 10.1016/0923-2508(96)81070-9. [DOI] [PubMed] [Google Scholar]
  15. Kramer M. D., Wallich R., Simon M. M. The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediator. Infection. 1996 Mar-Apr;24(2):190–194. doi: 10.1007/BF01713338. [DOI] [PubMed] [Google Scholar]
  16. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  17. Le Hénaff M., Brenner C., Fontenelle C., Delamarche C., Wróblewski H. La spiraline possède-t-elle une séquence signal N-terminale clivable? C R Acad Sci III. 1991;312(5):189–195. [PubMed] [Google Scholar]
  18. Lecoeur H., Gougeon M. L. Comparative analysis of flow cytometric methods for apoptosis quantitation in murine thymocytes and human peripheral lymphocytes from controls and HIV-infected persons. Evidence for interference by granulocytes and erythrocytes. J Immunol Methods. 1996 Oct 30;198(1):87–99. doi: 10.1016/0022-1759(96)00148-2. [DOI] [PubMed] [Google Scholar]
  19. Ma Y., Weis J. J. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun. 1993 Sep;61(9):3843–3853. doi: 10.1128/iai.61.9.3843-3853.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Melchers F., Braun V., Galanos C. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med. 1975 Aug 1;142(2):473–482. doi: 10.1084/jem.142.2.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mond J. J., Lees A., Snapper C. M. T cell-independent antigens type 2. Annu Rev Immunol. 1995;13:655–692. doi: 10.1146/annurev.iy.13.040195.003255. [DOI] [PubMed] [Google Scholar]
  22. Morioka H., Tachibana M., Machino M., Suganuma A. Polymyxin B binding sites in Escherichia coli as revealed by polymyxin B-gold labeling. J Histochem Cytochem. 1987 Feb;35(2):229–231. doi: 10.1177/35.2.3025293. [DOI] [PubMed] [Google Scholar]
  23. Mühlradt P. F., Kiess M., Meyer H., Süssmuth R., Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med. 1997 Jun 2;185(11):1951–1958. doi: 10.1084/jem.185.11.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Norgard M. V., Arndt L. L., Akins D. R., Curetty L. L., Harrich D. A., Radolf J. D. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B. Infect Immun. 1996 Sep;64(9):3845–3852. doi: 10.1128/iai.64.9.3845-3852.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pietsch K., Ehlers S., Jacobs E. Cytokine gene expression in the lungs of BALB/c mice during primary and secondary intranasal infection with Mycoplasma pneumoniae. Microbiology. 1994 Aug;140(Pt 8):2043–2048. doi: 10.1099/13500872-140-8-2043. [DOI] [PubMed] [Google Scholar]
  26. Radolf J. D., Arndt L. L., Akins D. R., Curetty L. L., Levi M. E., Shen Y., Davis L. S., Norgard M. V. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol. 1995 Mar 15;154(6):2866–2877. [PubMed] [Google Scholar]
  27. Rawadi G., Roman-Roman S., Castedo M., Dutilleul V., Susin S., Marchetti P., Geuskens M., Kroemer G. Effects of Mycoplasma fermentans on the myelomonocytic lineage. Different molecular entities with cytokine-inducing and cytocidal potential. J Immunol. 1996 Jan 15;156(2):670–678. [PubMed] [Google Scholar]
  28. Rawadi G., Roman-Roman S. Mycoplasma membrane lipoproteins induced proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect Immun. 1996 Feb;64(2):637–643. doi: 10.1128/iai.64.2.637-643.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ruuth E., Praz F. Interactions between mycoplasmas and the immune system. Immunol Rev. 1989 Dec;112:133–160. doi: 10.1111/j.1600-065x.1989.tb00556.x. [DOI] [PubMed] [Google Scholar]
  30. Sadziene A., Barbour A. G. Experimental immunization against Lyme borreliosis with recombinant Osp proteins: an overview. Infection. 1996 Mar-Apr;24(2):195–202. doi: 10.1007/BF01713339. [DOI] [PubMed] [Google Scholar]
  31. Sasaki Y., Blanchard A., Watson H. L., Garcia S., Dulioust A., Montagnier L., Gougeon M. L. In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals. Infect Immun. 1995 Nov;63(11):4277–4283. doi: 10.1128/iai.63.11.4277-4283.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Shimizu T., Iwamoto Y., Yanagihara Y., Kurimura M., Achiwa K. Mitogenic activity and the induction of tumor necrosis factor by lipopeptide analogs of the N-terminal part of lipoprotein in the outer membrane of Escherichia coli. Biol Pharm Bull. 1994 Jul;17(7):980–982. doi: 10.1248/bpb.17.980. [DOI] [PubMed] [Google Scholar]
  33. Snapper C. M., Yamaguchi H., Moorman M. A., Sneed R., Smoot D., Mond J. J. Natural killer cells induce activated murine B cells to secrete Ig. J Immunol. 1993 Nov 15;151(10):5251–5260. [PubMed] [Google Scholar]
  34. Stuart P. M., Egan R. M., Woodward J. G. Characterization of MHC induction by Mycoplasma fermentans (incognitus strain). Cell Immunol. 1993 Nov;152(1):261–270. doi: 10.1006/cimm.1993.1286. [DOI] [PubMed] [Google Scholar]
  35. Watson H. L., Zheng X., Cassell G. H. Structural variations and phenotypic switching of mycoplasmal antigens. Clin Infect Dis. 1993 Aug;17 (Suppl 1):S183–S186. doi: 10.1093/clinids/17.supplement_1.s183. [DOI] [PubMed] [Google Scholar]
  36. Wise K. S. Adaptive surface variation in mycoplasmas. Trends Microbiol. 1993 May;1(2):59–63. doi: 10.1016/0966-842X(93)90034-O. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wróblewski H., Johansson K. E., Hjérten S. Purification and characterization of spiralin, the main protein of the Spiroplasma citri membrane. Biochim Biophys Acta. 1977 Mar 1;465(2):275–289. doi: 10.1016/0005-2736(77)90079-7. [DOI] [PubMed] [Google Scholar]
  38. Wróblewski H., Nyström S., Blanchard A., Wieslander A. Topology and acylation of spiralin. J Bacteriol. 1989 Sep;171(9):5039–5047. doi: 10.1128/jb.171.9.5039-5047.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Zhong W., Wiesmüller K. H., Kramer M. D., Wallich R., Simon M. M. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo. Eur J Immunol. 1996 Nov;26(11):2749–2757. doi: 10.1002/eji.1830261130. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES